KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Non-Current Liabilities (2016 - 2026)

Supernus Pharmaceuticals has reported Total Non-Current Liabilities over the past 15 years, most recently at $368.7 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 13.55% to $368.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $368.7 million through Dec 2025, up 13.55% year-over-year, with the annual reading at $368.7 million for FY2025, 13.55% up from the prior year.
  • Total Non-Current Liabilities was $368.7 million for Q4 2025 at Supernus Pharmaceuticals, up from $362.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $843.9 million in Q2 2022 and troughed at $309.1 million in Q1 2025.
  • The 5-year median for Total Non-Current Liabilities is $371.3 million (2024), against an average of $540.5 million.
  • Year-over-year, Total Non-Current Liabilities increased 25.86% in 2021 and then crashed 62.19% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $837.7 million in 2021, then fell by 3.59% to $807.6 million in 2022, then tumbled by 56.7% to $349.7 million in 2023, then dropped by 7.15% to $324.7 million in 2024, then rose by 13.55% to $368.7 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Non-Current Liabilities are $368.7 million (Q4 2025), $362.3 million (Q3 2025), and $318.5 million (Q2 2025).